The suit seeks injunctive relief and damages for infringement of three of the Andersen family of patents for transcatheter heart valve technology. These patents relate to valve prosthesis for implantation by means of a catheter, and the product named in the suit is the CoreValve ReValving System.
Bruce Garren, corporate vice president and general counsel for Edwards, said: “Edwards has a significant portfolio of patents in transcatheter heart valve technology, led by the Andersen patent family, and we are committed to protecting this valuable intellectual property and the interests of our clinician-inventors.”